• The Biden administration has submitted a proposed $6 billion arms sale to Israel for congressional review, including advanced missiles, bombs, and technical support.
  • Key U.S. defense contractors like Boeing, Lockheed Martin, Raytheon, and General Dynamics are set to supply the munitions, with deliveries spanning several years.
  • The deal reinforces the U.S.-Israel strategic partnership but faces increasing scrutiny from some lawmakers and human rights groups concerned about the ongoing conflict in Gaza.

The U.S. government is moving forward with a significant new arms package for Israel, according to people familiar with the matter, underscoring a deep and enduring military alliance even as the political landscape grows more complex. The proposed sale, valued at approximately $6 billion, is currently undergoing a standard congressional review process.

The latest tranche includes a range of sophisticated munitions, such as AIM-120C-8 AMRAAM air-to-air missiles, Hellfire AGM-114 missiles, 155mm artillery shells, and Joint Direct Attack Munition (JDAM) tail kits. The package also encompasses 500-pound warheads, small diameter bombs, and bunker buster bombs, according to details of the submission. While some items are slated for delivery this year to address immediate needs, the majority of the equipment is scheduled to arrive over a multi-year period, signaling a long-term commitment to Israel's defense capabilities.

This substantial deal involves several major U.S. defense primes. Boeing, a key supplier of systems like Apache helicopters and components for the AMRAAM missiles, is a central player. Lockheed Martin, which specializes in precision munitions, Raytheon, a producer of air-to-air missiles and bomb kits, and General Dynamics, a manufacturer of artillery shells and bomb bodies, are also integral to the proposed sale. These companies have recently reported robust growth in their defense segments, fueled by heightened global demand for advanced weaponry.

The proposed sale arrives amid Israel's prolonged military operations and escalating regional tensions. Administration officials have consistently framed such transfers as critical for Israel's self-defense and have asserted they will not alter the regional military balance. However, the scale and timing have ignited fresh debate. A small but growing number of lawmakers have introduced resolutions aimed at blocking major sales, though most efforts have so far been unsuccessful. Congressional aides note that the review period allows for such challenges, but the administration maintains broad support for the initiative.

Efforts to reach spokespeople at the involved defense companies for immediate comment were not immediately successful. A State Department official, speaking on background, reiterated that all proposed arms transfers undergo a "rigorous and holistic review" to ensure they align with U.S. foreign policy and national security objectives.

The deal is part of a broader pattern of escalating weapons transfers. Earlier in the year, additional packages totaling over $7 billion were approved, and in August, the administration formalized five major Foreign Military Sales to Israel valued at over $20 billion, which included future deliveries of advanced fighter jets. This consistent flow of material highlights the strategic depth of the partnership and the sustained financial benefit for the U.S. defense industrial base, supporting high-skilled manufacturing jobs and contributing to export figures. For Israel, the acquisitions are pivotal for maintaining air and ground superiority and involve significant local job creation in military logistics and technology sectors.